We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+5.94%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$447B
AUM Growth
+$39.1B
Cap. Flow
-$684M
Cap. Flow %
-0.15%
Top 10 Hldgs %
27.16%
Holding
15,073
New
1,965
Increased
5,545
Reduced
5,814
Closed
1,500

Top Buys

Rank Stock Value
1
T icon
AT&T
T
+$877M
2
BKNG icon
Booking.com
BKNG
+$370M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$329M
4
BA icon
Boeing
BA
+$303M
5
WMT icon
Walmart Inc
WMT
+$291M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$544M
2
MBB icon
iShares MBS ETF
MBB
+$461M
3
NVDA icon
NVIDIA
NVDA
+$452M
4
TMUS icon
T-Mobile US
TMUS
+$426M
5
AAPL icon
Apple
AAPL
+$408M

Sector Composition

Rank Sector Weight
1 Technology 3.15%
2 Healthcare 3.06%
3 Financials 2.35%
4 Consumer Discretionary 2.28%
5 Industrials 1.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SXC icon
12651
PUT
SunCoke Energy
SXC
$794M
$114K ﹤0.01%
16,000
+5,100
+47% +$36.3K
WHLM
12652
DELISTED
Wilhelmina International, Inc
WHLM
$114K ﹤0.01%
22,892
+5,512
+32% +$30.4K
GENE
12653
DELISTED
Genetic Technologies Ltd.
GENE
$114K ﹤0.01%
5,370
-15,628
-74% -$315K
EUCRU
12654
DELISTED
Eucrates Biomedical Acquisition Corp. Unit
EUCRU
$114K ﹤0.01%
+11,168
New +$112K
FSRD
12655
DELISTED
Fast Radius, Inc. Class A Common Stock
FSRD
$114K ﹤0.01%
+11,691
New +$115K
HBP
12656
DELISTED
Huttig Building Products, Inc.
HBP
$114K ﹤0.01%
19,722
-16,861
-46% -$89.2K
ZIXI
12657
PUT
DELISTED
Zix Corporation
ZIXI
$114K ﹤0.01%
16,100
+3,500
+28% +$25.3K
NEBC
12658
PUT
DELISTED
Nebula Caravel Acquisition Corp. Class A Common Stock
NEBC
$114K ﹤0.01%
+11,400
New +$113K
PFSW
12659
PUT
DELISTED
PFSweb, Inc.
PFSW
$114K ﹤0.01%
+15,400
New +$114K
DMAC icon
12660
DiaMedica Therapeutics
DMAC
$360M
$113K ﹤0.01%
25,398
+4,797
+23% +$39.3K
STG
12661
Sunlands Technology
STG
$44.5M
$113K ﹤0.01%
9,035
+4,804
+114% +$61.4K
TAIT
12662
DELISTED
Taitron Components
TAIT
$113K ﹤0.01%
+22,721
New +$113K
TMC icon
12663
PUT
TMC The Metals Company
TMC
$1.77B
$113K ﹤0.01%
11,400
-248,200
-96% -$2.46M
UONEK icon
12664
Urban One Class D
UONEK
$23.4M
$113K ﹤0.01%
2,259
-2,976
-57% -$104K
TCON
12665
PUT
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$113K ﹤0.01%
870
-325
-27% -$44.9K
COMS
12666
DELISTED
COMSovereign Holding Corp. Common Stock
COMS
$113K ﹤0.01%
489
-1,114
-69% -$259K
ARBGU
12667
DELISTED
Aequi Acquisition Corp Unit
ARBGU
$113K ﹤0.01%
+11,255
New +$113K
EPHY
12668
CALL
DELISTED
Epiphany Technology Acquisition Corp. Class A Common Stock
EPHY
$113K ﹤0.01%
+11,600
New +$113K
OPA.U
12669
DELISTED
Magnum Opus Acquisition Limited Units, each consisting of one Class A ordinary share and one-half redeemable warrant
OPA.U
$113K ﹤0.01%
11,301
-232
-2% -$2.32K
LJPC
12670
CALL
DELISTED
La Jolla Pharmaceutical Company
LJPC
$113K ﹤0.01%
26,400
+14,100
+115% +$60.4K
ADMA icon
12671
CALL
ADMA Biologics
ADMA
$2.12B
$112K ﹤0.01%
70,300
+6,300
+10% +$11.1K
CLPR
12672
Clipper Realty
CLPR
$54M
$112K ﹤0.01%
15,278
+336
+2% +$2.73K
UOKA
12673
DELISTED
MDJM Ltd
UOKA
$112K ﹤0.01%
19
-6
-24% -$28.6K
NAACU
12674
DELISTED
North Atlantic Acquisition Corporation Unit
NAACU
$112K ﹤0.01%
+11,177
New +$111K
PACXU
12675
DELISTED
Pioneer Merger Corp. Unit
PACXU
$112K ﹤0.01%
10,702
-652,020
-98% -$6.65M
505 506
507
508 509

Similar funds

Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Ken Griffin's Q2 2021 Portfolio in Review

As of Q2 2021, Ken Griffin held 15,073 positions worth $447B, up 9.6% from $408B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Ken Griffin's Q2 2021 filing shows 1,965 new, 5,545 increased, 5,814 reduced and 1,500 closed positions. Its largest new stake was Coinbase: 1,010,057 shares worth $256M. The largest sale was Microsoft, an estimated $544M.

By sector, the portfolio is most concentrated in Technology at 3.2% of assets, down from 3.9% a quarter earlier, followed by Healthcare and Financials.

  • Ken Griffin's largest Q2 2021 buy was Coinbase: 1,010,057 shares worth $256M.
  • Ken Griffin added most to AT&T in Q2 2021, an estimated $877M increase.
  • Ken Griffin's biggest Q2 2021 reduction was Microsoft, cutting an estimated $544M.
  • Ken Griffin fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $197M.
  • Ken Griffin's ten largest holdings make up 27% of its $447B portfolio in Q2 2021.
  • Ken Griffin opened 1,965 new positions and closed 1,500 in Q2 2021.
  • Ken Griffin's portfolio value rose 9.6% quarter-over-quarter to $447B.

Based on Citadel Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.